tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Fatty Liver D005234 48 associated lipids
Cataract D002386 34 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Precancerous Conditions D011230 48 associated lipids
Postoperative Complications D011183 5 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Mor E et al. Comparison of short and long-term renal function in liver transplant patients receiving cyclosporin or FK 506. 1994 Transpl. Int. pmid:11271340
Uemoto S et al. Long-term use of FK 506 in living related liver transplantation. 1994 Transpl. Int. pmid:11271341
Dmitrewski J et al. Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin? 1994 Transpl. Int. pmid:11271342
von Schnakenburg C et al. Post-transplant epididymitis and orchitis following Listeria monocytogenes septicaemia. 2000 Pediatr Transplant pmid:11272610
Martel J et al. [Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. 2001 Ann Dermatol Venereol pmid:11275588
Tahara K et al. Experimental small bowel transplantation using newborn intestine in rats: III. Long-term cryopreservation of rat newborn intestine. 2001 J. Pediatr. Surg. pmid:11283886
Krisp A and Hoffmann R [Letter concerning the article by E.C.Bornhövd, E.Schuller, T.Bieber, A.Wollenberg: "Immunosuppressive macrolides and their use in dermatology". Der Hautarzt (2000) 51:646-654]. 2001 Hautarzt pmid:11284076
Schwrer H et al. Pantoprazole and cyclosporine or tacrolimus. 2001 Aliment. Pharmacol. Ther. pmid:11284790
Kasper RC et al. Anetoderma arising in cutaneous B-cell lymphoproliferative disease. 2001 Am J Dermatopathol pmid:11285407
Trimarchi H et al. Cyclosporine-associated thrombotic microangiopathy during daclizumab induction: a suggested therapeutic approach. 2001 Nephron pmid:11287781
Fredduzzi S et al. Nitro-aspirin (NCX4016) reduces brain damage induced by focal cerebral ischemia in the rat. 2001 Neurosci. Lett. pmid:11290402
Lunz JG et al. Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs. 2001 Am. J. Pathol. pmid:11290556
Zoeteweij JP et al. Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus. 2001 Blood pmid:11290600
Fortin JF et al. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. 2001 Blood pmid:11290602
van Gelder T et al. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. 2001 Ther Drug Monit pmid:11294511
Macchi-Andanson M et al. Failure of traditional trough levels to predict tacrolimus concentrations. 2001 Ther Drug Monit pmid:11294512
Lener EV et al. Successful treatment of erosive lichen planus with topical tacrolimus. 2001 Arch Dermatol pmid:11295919
Ishikawa M et al. [Blood concentrations and side effects of tacrolimus in a living renal transplantation]. 2001 Masui pmid:11296433
Yada T et al. Its8, a fission yeast homolog of Mcd4 and Pig-n, is involved in GPI anchor synthesis and shares an essential function with calcineurin in cytokinesis. 2001 J. Biol. Chem. pmid:11297516
Griffiths CE Ascomycin: an advance in the management of atopic dermatitis. 2001 Br. J. Dermatol. pmid:11298524
Harper J et al. First experience of topical SDZ ASM 981 in children with atopic dermatitis. 2001 Br. J. Dermatol. pmid:11298537
Luger T et al. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. 2001 Br. J. Dermatol. pmid:11298538
Li S et al. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. 2001 Exp. Hematol. pmid:11301194
Arima H et al. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. 2001 J. Pharmacol. Exp. Ther. pmid:11303042
Shiraishi S et al. Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. 2001 J. Pharmacol. Exp. Ther. pmid:11303055
Mardini M et al. Cyclosporine and FK506 differentially regulate the sarcolemmal Na(+)-K(+) pump. 2001 J. Pharmacol. Exp. Ther. pmid:11303073
Trotter JF et al. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper). 2001 Liver Transpl. pmid:11303295
Jones NF et al. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation. 2001 Plast. Reconstr. Surg. pmid:11304605
Topical tacrolimus for treatment of atopic dermatitis. 2001 Med Lett Drugs Ther pmid:11309535
Sheehy EC et al. Oral health in children undergoing liver transplantation. 2000 Int J Paediatr Dent pmid:11310095
Monegal A et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. 2001 Calcif. Tissue Int. pmid:11310351
Freyschmidt-Paul P et al. Current and potential agents for the treatment of alopecia areata. 2001 Curr. Pharm. Des. pmid:11311114
Rumora L et al. MKP-1 as a target for pharmacological manipulations in PC12 cell survival. 2001 Neurochem. Int. pmid:11311446
Yoshimoto T et al. Cyclosporin A, but not FK506, prevents the downregulation of phosphorylated Akt after transient focal ischemia in the rat. 2001 Brain Res. pmid:11311876
Takatsuki M et al. Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. 2001 Transpl. Immunol. pmid:11316071
Smith KM and Van Etten RA Activation of c-Abl kinase activity and transformation by a chemical inducer of dimerization. 2001 J. Biol. Chem. pmid:11320088
Pohanka E et al. [Dosage and monitoring of tacrolimus after kidney transplantation]. 2000 Dtsch. Med. Wochenschr. pmid:11320722
Russell RK et al. Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease. 2001 J. Pediatr. Gastroenterol. Nutr. pmid:11321395
Strestíková P et al. Different mechanisms in inhibition of rat macrophage nitric oxide synthase expression by FK 506 and cyclosporin A. 2001 Immunopharmacol Immunotoxicol pmid:11322650
Gaziev D and Lucarelli G Novel approaches to the treatment of chronic graft-versus-host disease. 2001 Expert Opin Investig Drugs pmid:11322865
Lang-Lazdunski L et al. The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats. 2001 Anesth. Analg. pmid:11323353
Kennedy DS and Linden GJ Resolution of gingival overgrowth following change from cyclosporin to tacrolimus therapy in a renal transplant patient. 2000 J Ir Dent Assoc pmid:11323935
Weinberg JM and Silverberg NB A kinder, gentler therapy? 2001 Cutis pmid:11324387
Kulkarni P Review: uveitis and immunosuppressive drugs. 2001 J Ocul Pharmacol Ther pmid:11324985
Kawada N et al. Role of mast cells in antigen-induced airway inflammation and bronchial hyperresponsiveness in rats. 2001 Jpn. J. Pharmacol. pmid:11325017
Sche PP et al. Corrigendum to: "Display cloning: functional identification of natural product receptors using cDNA-phage display" [Chemistry & Biology 6 (1999) 707-716]. 2001 Chem. Biol. pmid:11325595
Mollee P et al. Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis. 2001 Br. J. Haematol. pmid:11328304
Dicarlo JB and McCall CO Pharmacologic alternatives for severe atopic dermatitis. 2001 Int. J. Dermatol. pmid:11328387
Mittal N et al. Tacrolimus and diarrhea: pathogenesis of altered metabolism. 2001 Pediatr Transplant pmid:11328543
Frühwirth M et al. Rotavirus infection as cause of tacrolimus elevation in solid-organ-transplanted children. 2001 Pediatr Transplant pmid:11328545
Jain A et al. Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. 2001 Pediatr Transplant pmid:11328546
MacFarlane GD et al. Therapeutic drug monitoring of tacrolimus in pediatric liver transplant patients. 2001 Pediatr Transplant pmid:11328550
Dobrolet NC et al. Hematologic abnormalities in children and young adults receiving tacrolimus-based immunosuppression following cardiothoracic transplantation. 2001 Pediatr Transplant pmid:11328551
Frühwirth M et al. Elevated tacrolimus trough levels in association with mycophenolate mofetil-induced diarrhea: a case report. 2001 Pediatr Transplant pmid:11328552
Ogawa Y et al. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. 2001 Cornea pmid:11333336
pmid:11334064
Mackinnon SE et al. Clinical outcome following nerve allograft transplantation. 2001 Plast. Reconstr. Surg. pmid:11335811
Parasrampuria DA et al. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function. 2001 Pharm. Res. pmid:11336351
Lee TH Skin disease. Eczema. 2001 Harv Health Lett pmid:11340028
Obata K et al. Role of FK506-binding protein 12 in development of the chick embryonic heart. 2001 Biochem. Biophys. Res. Commun. pmid:11341768
De Bonis M et al. Tacrolimus as a rescue immunosuppressant after heart transplantation. 2001 Eur J Cardiothorac Surg pmid:11343954
Treede H et al. Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols. 2001 J. Heart Lung Transplant. pmid:11343977
Yan M et al. The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. 2001 FASEB J. pmid:11344081
Sutherland DE et al. Pancreas transplantation for treatment of diabetes mellitus. 2001 World J Surg pmid:11344403
Skaehill PA Tacrolimus in dermatologic disorders. 2001 Ann Pharmacother pmid:11346066
Kawamura I et al. Induction of choleresis by immunosuppressant FK506 through stimulation of insulin-like growth factor-I production in the liver of rats. 2001 Eur. J. Pharmacol. pmid:11348636
Trotter JF et al. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. 2001 Liver Transpl. pmid:11349259
Ahuja M et al. Polyoma virus infection after renal transplantation. Use of immunostaining as a guide to diagnosis. 2001 Transplantation pmid:11349723
Pérgola PE et al. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. 2001 Transplantation pmid:11349738
Stover JF et al. Effects of tacrolimus on hemispheric water content and cerebrospinal fluid levels of glutamate, hypoxanthine, interleukin-6, and tumor necrosis factor-alpha following controlled cortical impact injury in rats. 2001 J. Neurosurg. pmid:11354410
Yang DY et al. Simultaneous monitoring of extracellular glucose, pyruvate, lactate and glutamate in gerbil cortex during focal cerebral ischemia by dual probe microdialysis. 2001 J Chromatogr A pmid:11355832
Arima H et al. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats. 2001 J Pharm Sci pmid:11357172
Sakuma S et al. Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro. 2001 Int. Immunopharmacol. pmid:11357886
Ebisu T et al. Early and delayed neuroprotective effects of FK506 on experimental focal ischemia quantitatively assessed by diffusion-weighted MRI. 2001 Magn Reson Imaging pmid:11358652
Guo X et al. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. 2001 Eur. J. Neurosci. pmid:11359520
Lensmeyer GL and Poquette MA Therapeutic monitoring of tacrolimus concentrations in blood: semi-automated extraction and liquid chromatography-electrospray ionization mass spectrometry. 2001 Ther Drug Monit pmid:11360032
Venkataramanan R et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. 2001 J Clin Pharmacol pmid:11361051
Wallemacq PE and Verbeeck RK Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. 2001 Clin Pharmacokinet pmid:11368293
Otto KG et al. Cell proliferation through forced engagement of c-Kit and Flt-3. 2001 Blood pmid:11369667
Morales JM et al. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. 2001 Nephrol. Dial. Transplant. pmid:11369839
Goldman D Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. 2001 J. Am. Acad. Dermatol. pmid:11369912
Poirier SN et al. FK506 blocks intracellular Ca2+ oscillations in bovine adrenal glomerulosa cells. 2001 Biochemistry pmid:11371212
Hashida T et al. Pharmacokinetic and prognostic significance of intestinal MDR1 expression in recipients of living-donor liver transplantation. 2001 Clin. Pharmacol. Ther. pmid:11371998
Mathis AS et al. Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. 2001 Transplantation pmid:11374405
Jain A et al. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. 2001 Transplantation pmid:11374410
Neumann UP et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. 2001 Transplantation pmid:11374419
Yamamoto-Yamaguchi Y et al. Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. 2001 Exp. Hematol. pmid:11376870
Paul LC Overview of side effects of immunosuppressive therapy. 2001 Transplant. Proc. pmid:11377462
Ierardi E et al. Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. 2001 Transplant. Proc. pmid:11377467
Bilbao I et al. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. 2001 Transplant. Proc. pmid:11377472
Braun F et al. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. 2001 Transplant. Proc. pmid:11377473
Gerbase MW et al. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation. 2001 Transplant. Proc. pmid:11377481
Gerhardt U et al. High QT dispersion in tacrolimus-treated kidney transplant recipients. 2001 Transplant. Proc. pmid:11377482
Hesse CJ et al. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation. 2001 Transplant. Proc. pmid:11377487
Klupp J et al. New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus. 2001 Transplant. Proc. pmid:11377491
McGrath JS and Shehata M The effect of differing immunosuppressive regimes on the functional and morphologic changes in a rat renal allograft model of chronic rejection. 2001 Transplant. Proc. pmid:11377499
McGrath JS and Shehata M Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution. 2001 Transplant. Proc. pmid:11377500
Kelly JS and Sharkey J Immunosuppressants-ligands as neuroprotectants. 2001 Transplant. Proc. pmid:11377506
Mohacsi P et al. Immunosuppression in ABO-incompatible transplantation. 2001 Transplant. Proc. pmid:11377508
Jonas S et al. Corticosteroid-free therapy after tacrolimus-based dual immunosuppression versus cyclosporine-based quadruple-induction therapy. 2001 Transplant. Proc. pmid:11377511